Neogene Therapeutics Stock

A biotechnology company developing next-generation, fully personalized T-cell therapies for a wide range of cancers. It focuses on researching and engineering T-cells that target mutated proteins in cancer cells—neo-antigens arising from cancer-related DNA mutations—making tumor cells more detectable by T-cells and enhancing cancer treatment.